ABC designs and creates therapeutics that target diseases of the future. ABC also sources innovative technologies from globally reputable academia and med tech companies to accelerate market arrivals of novel and necessary medical interventions

ABC follows strict FDA regulations to develop institution-tested and government-regulated medicines. ABC develops and sponsors cell and gene therapy and immunotherapy technologies.

ABC overcomes the traditional regulatory bureaucracy that hinders drug development by launching the first ABC Commercialization Platform in Thailand- the medical hub of Southeast Asia.
Working with shorter bureaucratic queues at Thai FDA, and enjoying the national attention focused on new technologies, ABC’s strong biotech and academic partnerships accelerate the clinical trials and regulatory approvals processes.

ABC looks forward to leveraging its relationships with clinicians and hospital groupsto smoothly commercialize approved technologies for the mass market. Groundbreaking technologies may be available as early as late 2025.
